跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
M-EDIAT - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
M-EDIAT
Authorized
STANDARD
M-EDIAT
Ethypharm Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
0042cd4c8127abd9
Company
Ethypharm Inc
Type
Standard
Approval Details
Approval Id
0042cd4c8127abd9
Drug Approval Canada Name
M-EDIAT
Product Name
M-EDIAT
Status
Marketed
Status Date
2025-06-13
Original Market Date
2016-09-06
Din
02320444
Drug Class
Human
Dosage Form
Capsule (Immediate Release)
Route Of Administration
Oral
Schedule
Narcotic (CDSA I)
Ahfs
28:08.08
Atc Original
N02AA01 MORPHINE
Atc Name
n 02 aa 01
Aig Number
0104545011
Company Name
Ethypharm Inc
Company Address
SUITE 1500, 1200 Avenue Mcgill College, Montreal, Quebec, Canada, H3B 4G7
Company Detail Path
/organization/ethypharm-inc
Company Information
Pharmaceutical Company Name
Ethypharm Inc
Country Name
Canada
Province Name
Quebec
City Name
montréal,quebec,country_ca
Address
1000 rue de la Gauchetière O bureau 2400
Active Ingredients
MORPHINE SULFATE
30 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
0042cd4c8127abd9
Type
Standard
Back to Health Canada Approvals